PUBLISHER: KBV Research | PRODUCT CODE: 1245256
PUBLISHER: KBV Research | PRODUCT CODE: 1245256
Asia Pacific Cluster Headache Market Size, Share & Industry Trends Analysis Report By Distribution channel, By Type, By Drug Class, By Country and Growth Forecast, 2022 - 2028
The Asia Pacific Cluster Headache Market would witness market growth of 4.8% CAGR during the forecast period (2022-2028).
Periodic headache-causing triggers include the brain's blood vessels shifting in response to headaches. People become more susceptible to nicotine and alcohol due to these changes. Even a small amount of alcohol consumption might cause headaches. Smoking can also exacerbate headaches or even cause them. Just on the side of the headache the nose starts to flow or get stuffy. Eye issues include eye discomfort, watery eyes, and drooping eyelids. The patient's pupil, which is the dark spot in the middle of the eye, could also appear smaller. On the headache side, patients can start sweating, and their face might get flushed.
Even though cluster headaches are incurable, some treatments might lessen their discomfort. Abortive care to halt attacks: A headache frequently ends before the patient can consult a doctor. Yet, several efficient techniques exist to stop a cluster headache if the patient acts quickly. One could receive a nasal spray or an injection of medicine from a medical professional. Sumatriptan, dihydroergotamine, and zolmitriptan are a few of them. They could also receive oxygen from the supplier via a mask.
The pharmaceutical sector in India is worth $50 billion. 3.5% of all medications and medicines shipped internationally to more than 200 nations come from this nation. The Department of Pharmaceuticals has introduced three supporting programs to encourage international and domestic players to increase investment and production in these product categories to ensure greater resilience to external shocks, enforce greater drug security, and increase domestic production capacity for critical bulk drugs high-value products alike. The Schemes are intended to increase the Indian pharmaceutical industry's resilience to external shocks and significantly advance the achievement of a higher goal of sustainable access to inexpensive healthcare domestically and abroad. This supports the growth of the regional market.
The China market dominated the Asia Pacific Cluster Headache Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $34.5 Million by 2028. The Japan market is estimated to grow a CAGR of 4.2% during (2022 - 2028). Additionally, The India market would display a CAGR of 5.4% during (2022 - 2028).
Based on Distribution channel, the market is segmented into Drug Stores & Retail Pharmacies, Hospital Pharmacies, and Others. Based on Type, the market is segmented Episodic, and Chronic. Based on Drug Class, the market is segmented into Triptans, Calcium Channel Blockers, Ergot Derivatives, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Dr. Reddy's Laboratories Ltd., Novartis AG, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., GlaxoSmithKline PLC (GSK), Pfizer, Inc., Fresenius SE & Co. KGaA, Eli Lilly And Company, Grunenthal GmbH, and Arrotex Pharmaceuticals Pty Limited.
Scope of the Study
Market Segments covered in the Report:
By Distribution channel
- Drug Stores & Retail Pharmacies
- Hospital Pharmacies
- Others
By Type
- Episodic
- Chronic
By Drug Class
- Triptans
- Calcium Channel Blockers
- Ergot Derivatives
- Others
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Companies Profiled
- Dr. Reddy's Laboratories Ltd.
- Novartis AG
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- GlaxoSmithKline PLC (GSK)
- Pfizer, Inc.
- Fresenius SE & Co. KGaA
- Eli Lilly And Company
- Grunenthal GmbH
- Arrotex Pharmaceuticals Pty Limited
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 Asia Pacific Cluster Headache Market, by Distribution channel
- 1.4.2 Asia Pacific Cluster Headache Market, by Type
- 1.4.3 Asia Pacific Cluster Headache Market, by Drug Class
- 1.4.4 Asia Pacific Cluster Headache Market, by Country
- 1.5 Methodology for the research
Chapter 2. Market Overview
- 2.1 Introduction
- 2.1.1 Overview
- 2.1.1.1 Market composition & scenario
- 2.1.1 Overview
- 2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints
Chapter 3. Asia Pacific Cluster Headache Market by Distribution channel
- 3.1 Asia Pacific Drug Stores & Retail Pharmacies Market by Country
- 3.2 Asia Pacific Hospital Pharmacies Market by Country
- 3.3 Asia Pacific Others Market by Country
Chapter 4. Asia Pacific Cluster Headache Market by Type
- 4.1 Asia Pacific Episodic Market by Country
- 4.2 Asia Pacific Chronic Market by Country
Chapter 5. Asia Pacific Cluster Headache Market by Drug Class
- 5.1 Asia Pacific Triptans Market by Country
- 5.2 Asia Pacific Calcium Channel Blockers Market by Country
- 5.3 Asia Pacific Ergot Derivatives Market by Country
- 5.4 Asia Pacific Others Market by Country
Chapter 6. Asia Pacific Cluster Headache Market by Country
- 6.1 China Cluster Headache Market
- 6.1.1 China Cluster Headache Market by Distribution channel
- 6.1.2 China Cluster Headache Market by Type
- 6.1.3 China Cluster Headache Market by Drug Class
- 6.2 Japan Cluster Headache Market
- 6.2.1 Japan Cluster Headache Market by Distribution channel
- 6.2.2 Japan Cluster Headache Market by Type
- 6.2.3 Japan Cluster Headache Market by Drug Class
- 6.3 India Cluster Headache Market
- 6.3.1 India Cluster Headache Market by Distribution channel
- 6.3.2 India Cluster Headache Market by Type
- 6.3.3 India Cluster Headache Market by Drug Class
- 6.4 South Korea Cluster Headache Market
- 6.4.1 South Korea Cluster Headache Market by Distribution channel
- 6.4.2 South Korea Cluster Headache Market by Type
- 6.4.3 South Korea Cluster Headache Market by Drug Class
- 6.5 Singapore Cluster Headache Market
- 6.5.1 Singapore Cluster Headache Market by Distribution channel
- 6.5.2 Singapore Cluster Headache Market by Type
- 6.5.3 Singapore Cluster Headache Market by Drug Class
- 6.6 Malaysia Cluster Headache Market
- 6.6.1 Malaysia Cluster Headache Market by Distribution channel
- 6.6.2 Malaysia Cluster Headache Market by Type
- 6.6.3 Malaysia Cluster Headache Market by Drug Class
- 6.7 Rest of Asia Pacific Cluster Headache Market
- 6.7.1 Rest of Asia Pacific Cluster Headache Market by Distribution channel
- 6.7.2 Rest of Asia Pacific Cluster Headache Market by Type
- 6.7.3 Rest of Asia Pacific Cluster Headache Market by Drug Class
Chapter 7. Company Profiles
- 7.1 Dr. Reddy's Laboratories Ltd.
- 7.1.1 Company Overview
- 7.1.2 Financial Analysis
- 7.1.3 Segmental and Regional Analysis
- 7.1.4 Research & Development Expense
- 7.2 Novartis AG
- 7.2.1 Company Overview
- 7.2.2 Financial Analysis
- 7.2.3 Segmental and Regional Analysis
- 7.2.4 Research & Development Expense
- 7.3 Sun Pharmaceutical Industries Ltd.
- 7.3.1 Company Overview
- 7.3.2 Financial Analysis
- 7.3.3 Regional & Segmental Analysis
- 7.3.4 Research & Development Expenses
- 7.4 Teva Pharmaceutical Industries Ltd.
- 7.4.1 Company Overview
- 7.4.2 Financial Analysis
- 7.4.3 Regional Analysis
- 7.4.4 Research & Development Expenses
- 7.5 GlaxoSmithKline PLC (GSK)
- 7.5.1 Company Overview
- 7.5.2 Financial Analysis
- 7.5.3 Segmental and Regional Analysis
- 7.5.4 Research & Development Expense
- 7.6 Pfizer, Inc.
- 7.6.1 Company Overview
- 7.6.2 Financial Analysis
- 7.6.3 Regional & Segmental Analysis
- 7.6.4 Research & Development Expense
- 7.7 Fresenius SE & Co. KGaA
- 7.7.1 Company Overview
- 7.7.2 Financial Analysis
- 7.7.3 Segmental and Regional Analysis
- 7.7.4 Research & Development Expenses
- 7.8 Eli Lilly And Company
- 7.8.1 Company Overview
- 7.8.2 Financial Analysis
- 7.8.3 Regional Analysis
- 7.8.4 Research & Development Expenses
- 7.9 Grunenthal GmbH
- 7.9.1 Company Overview
- 7.9.2 Financial Analysis
- 7.9.3 Segmental and Regional Analysis
- 7.9.4 Research & Development Expenses
- 7.10. Arrotex Pharmaceuticals Pty Limited
- 7.10.1 Company Overview
LIST OF TABLES
- TABLE 1 Asia Pacific Cluster Headache Market, 2018 - 2021, USD Million
- TABLE 2 Asia Pacific Cluster Headache Market, 2022 - 2028, USD Million
- TABLE 3 Asia Pacific Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
- TABLE 4 Asia Pacific Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
- TABLE 5 Asia Pacific Drug Stores & Retail Pharmacies Market by Country, 2018 - 2021, USD Million
- TABLE 6 Asia Pacific Drug Stores & Retail Pharmacies Market by Country, 2022 - 2028, USD Million
- TABLE 7 Asia Pacific Hospital Pharmacies Market by Country, 2018 - 2021, USD Million
- TABLE 8 Asia Pacific Hospital Pharmacies Market by Country, 2022 - 2028, USD Million
- TABLE 9 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
- TABLE 10 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
- TABLE 11 Asia Pacific Cluster Headache Market by Type, 2018 - 2021, USD Million
- TABLE 12 Asia Pacific Cluster Headache Market by Type, 2022 - 2028, USD Million
- TABLE 13 Asia Pacific Episodic Market by Country, 2018 - 2021, USD Million
- TABLE 14 Asia Pacific Episodic Market by Country, 2022 - 2028, USD Million
- TABLE 15 Asia Pacific Chronic Market by Country, 2018 - 2021, USD Million
- TABLE 16 Asia Pacific Chronic Market by Country, 2022 - 2028, USD Million
- TABLE 17 Asia Pacific Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
- TABLE 18 Asia Pacific Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
- TABLE 19 Asia Pacific Triptans Market by Country, 2018 - 2021, USD Million
- TABLE 20 Asia Pacific Triptans Market by Country, 2022 - 2028, USD Million
- TABLE 21 Asia Pacific Calcium Channel Blockers Market by Country, 2018 - 2021, USD Million
- TABLE 22 Asia Pacific Calcium Channel Blockers Market by Country, 2022 - 2028, USD Million
- TABLE 23 Asia Pacific Ergot Derivatives Market by Country, 2018 - 2021, USD Million
- TABLE 24 Asia Pacific Ergot Derivatives Market by Country, 2022 - 2028, USD Million
- TABLE 25 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
- TABLE 26 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
- TABLE 27 Asia Pacific Cluster Headache Market by Country, 2018 - 2021, USD Million
- TABLE 28 Asia Pacific Cluster Headache Market by Country, 2022 - 2028, USD Million
- TABLE 29 China Cluster Headache Market, 2018 - 2021, USD Million
- TABLE 30 China Cluster Headache Market, 2022 - 2028, USD Million
- TABLE 31 China Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
- TABLE 32 China Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
- TABLE 33 China Cluster Headache Market by Type, 2018 - 2021, USD Million
- TABLE 34 China Cluster Headache Market by Type, 2022 - 2028, USD Million
- TABLE 35 China Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
- TABLE 36 China Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
- TABLE 37 Japan Cluster Headache Market, 2018 - 2021, USD Million
- TABLE 38 Japan Cluster Headache Market, 2022 - 2028, USD Million
- TABLE 39 Japan Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
- TABLE 40 Japan Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
- TABLE 41 Japan Cluster Headache Market by Type, 2018 - 2021, USD Million
- TABLE 42 Japan Cluster Headache Market by Type, 2022 - 2028, USD Million
- TABLE 43 Japan Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
- TABLE 44 Japan Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
- TABLE 45 India Cluster Headache Market, 2018 - 2021, USD Million
- TABLE 46 India Cluster Headache Market, 2022 - 2028, USD Million
- TABLE 47 India Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
- TABLE 48 India Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
- TABLE 49 India Cluster Headache Market by Type, 2018 - 2021, USD Million
- TABLE 50 India Cluster Headache Market by Type, 2022 - 2028, USD Million
- TABLE 51 India Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
- TABLE 52 India Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
- TABLE 53 South Korea Cluster Headache Market, 2018 - 2021, USD Million
- TABLE 54 South Korea Cluster Headache Market, 2022 - 2028, USD Million
- TABLE 55 South Korea Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
- TABLE 56 South Korea Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
- TABLE 57 South Korea Cluster Headache Market by Type, 2018 - 2021, USD Million
- TABLE 58 South Korea Cluster Headache Market by Type, 2022 - 2028, USD Million
- TABLE 59 South Korea Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
- TABLE 60 South Korea Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
- TABLE 61 Singapore Cluster Headache Market, 2018 - 2021, USD Million
- TABLE 62 Singapore Cluster Headache Market, 2022 - 2028, USD Million
- TABLE 63 Singapore Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
- TABLE 64 Singapore Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
- TABLE 65 Singapore Cluster Headache Market by Type, 2018 - 2021, USD Million
- TABLE 66 Singapore Cluster Headache Market by Type, 2022 - 2028, USD Million
- TABLE 67 Singapore Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
- TABLE 68 Singapore Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
- TABLE 69 Malaysia Cluster Headache Market, 2018 - 2021, USD Million
- TABLE 70 Malaysia Cluster Headache Market, 2022 - 2028, USD Million
- TABLE 71 Malaysia Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
- TABLE 72 Malaysia Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
- TABLE 73 Malaysia Cluster Headache Market by Type, 2018 - 2021, USD Million
- TABLE 74 Malaysia Cluster Headache Market by Type, 2022 - 2028, USD Million
- TABLE 75 Malaysia Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
- TABLE 76 Malaysia Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
- TABLE 77 Rest of Asia Pacific Cluster Headache Market, 2018 - 2021, USD Million
- TABLE 78 Rest of Asia Pacific Cluster Headache Market, 2022 - 2028, USD Million
- TABLE 79 Rest of Asia Pacific Cluster Headache Market by Distribution channel, 2018 - 2021, USD Million
- TABLE 80 Rest of Asia Pacific Cluster Headache Market by Distribution channel, 2022 - 2028, USD Million
- TABLE 81 Rest of Asia Pacific Cluster Headache Market by Type, 2018 - 2021, USD Million
- TABLE 82 Rest of Asia Pacific Cluster Headache Market by Type, 2022 - 2028, USD Million
- TABLE 83 Rest of Asia Pacific Cluster Headache Market by Drug Class, 2018 - 2021, USD Million
- TABLE 84 Rest of Asia Pacific Cluster Headache Market by Drug Class, 2022 - 2028, USD Million
- TABLE 85 key information - Dr. Reddy's Laboratories Ltd.
- TABLE 86 Key Information - Novartis AG
- TABLE 87 Key Information - Sun Pharmaceutical Industries Ltd.
- TABLE 88 Key Information - Teva Pharmaceuticals Industries Ltd.
- TABLE 89 Key Information - GlaxoSmithKline PLC (GSK)
- TABLE 90 Key Information - Pfizer, Inc.
- TABLE 91 key information - Fresenius SE & Co. KGaA
- TABLE 92 Key Information - Eli Lilly And Company
- TABLE 93 Key Information - Grunenthal GmbH
- TABLE 94 Key Information - Arrotex Pharmaceuticals Pty Limited
List of Figures
- FIG 1 Methodology for the research
